Found: 8
Select item for more details and to access through your institution.
High prevalence of angle-closure glaucoma in Vogt-Koyanagi-Harada disease.
- Published in:
- International Ophthalmology, 2022, v. 42, n. 12, p. 3913, doi. 10.1007/s10792-022-02412-4
- By:
- Publication type:
- Article
Prevalence of angle closure disease in an ophthalmology teaching hospital before and after encouragement of gonioscopy.
- Published in:
- Vision Pan-America, 2016, v. 15, n. 4, p. 106
- By:
- Publication type:
- Article
Entrampamiento de iris en implante Ex-Press liberado por YAG laser: Reporte de un caso.
- Published in:
- Vision Pan-America, 2014, v. 13, n. 2, p. 59
- By:
- Publication type:
- Article
Efficacy and tolerability of fixed-combination bimatoprost/timolol versus fixed-combination dorzolamide/brimonidine/timolol in patients with primary open-angle glaucoma or ocular hypertension: a multicenter, prospective, crossover study.
- Published in:
- BMC Ophthalmology, 2014, v. 14, n. 1, p. 93, doi. 10.1186/1471-2415-14-161
- By:
- Publication type:
- Article
Efficacy and tolerability of fixed-combination bimatoprost/timolol versus fixed-combination dorzolamide/brimonidine/timolol in patients with primary open-angle glaucoma or ocular hypertension: a multicenter, prospective, crossover study.
- Published in:
- 2014
- By:
- Publication type:
- journal article
Risk factors for secondary Glaucoma in patients with Vogt-Koyanagi-Harada disease.
- Published in:
- Journal of Ophthalmic Inflammation & Infection, 2022, v. 12, n. 1, p. 1, doi. 10.1186/s12348-022-00300-7
- By:
- Publication type:
- Article
A Masked, Randomized, Phase 3 Comparison of Triple Fixed-Combination Bimatoprost/Brimonidine/Timolol versus Fixed-Combination Brimonidine/Timolol for Lowering Intraocular Pressure.
- Published in:
- Journal of Ophthalmology, 2017, p. 1, doi. 10.1155/2017/4586763
- By:
- Publication type:
- Article
A Phase III Randomized Clinical Trial of a 0.5% Timolol + 0.2% Brimonidine + 2.0% Dorzolamide Fixed Combination, Preservative-Free Ophthalmic Solution vs. 0.5% Timolol + 0.2% Brimonidine + 2.0% Dorzolamide Fixed Combination in Patients with Controlled Primary Open-Angle Glaucoma
- Published in:
- Ophthalmology & Therapy, 2018, v. 7, n. 1, p. 145, doi. 10.1007/s40123-018-0128-8
- By:
- Publication type:
- Article